Investigations

GRABAR LAW OFFICE INVESTIGATES CLAIMS ON BEHALF OF SHAREHOLDERS OF PARAGON 28, INC. (NYSE: FNA)

Paragon 28, Inc. (NYSE: FNA) states that it “develops, distributes, and sells medical devices in the foot and ankle segment of the orthopedic implant marketplace.” This class action was filed against the Company and three of its Officers.

A recently filed federal securities class action complaint alleges that throughout the

Period starting on May 5, 2023 ending on August 8, 2024, Paragon 28, through certain of its officers and directors, made false and/or misleading statements and/or failed to disclose that: (1) Paragon 28’s financial statements were misstated; (2) Paragon 28 lacked adequate internal controls and at times understated the extent of the issues with its internal controls; and (3) as a result, Defendants’ statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.

Shareholders who purchased Paragon 28 shares between May 5, 2023 and August 8, 2024, as well as longer term shareholders who purchased prior to May 5, 2023,  are encouraged to contact Joshua H. Grabar  at [email protected] or Mia R. Heller at [email protected], or call 267-507-6085.

Please enter your name.
Please enter a valid phone number.
Please enter a message.
Send

                                                                                           Attorney Advertising Disclaimer

  • Join This Action

  • Alternatively, you may upload your transactions using the upload button below or email them to [email protected]. *

  • Drop files here or
    Max. file size: 100 MB.
    • Signed pursuant to California Civil Code Section 1633.1, et seq. and the Uniform Electronic Transactions Act as adopted by the various states and territories of the United States.

    • Date of signing: *

    • MM slash DD slash YYYY
    • This field is for validation purposes and should be left unchanged.